ReviewFrontiers in psychiatry2026
Effects of maternal autoantibody exposure at the cellular level: implications for the developing brain.
Review in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Maternal autoimmunity during pregnancy can have significant impacts on fetal development. In the case of maternal autoantibody-related autism (MARA), autoantibodies (aABs) reactive to fetal brain proteins in the circulation of pregnant mothers have been strongly associated with an offspring autism diagnosis. Clinical studies have identified the protein targets for the MARA aABs as well as maternal aAB patterns that are more commonly observed in mothers of children with autism, but not in mothers of neurotypical children. Additionally, rodent studies show that gestational exposure to MARA aABs alters offspring brain development and behavior. How MARA aABs cause changes at the cellular level is an area of active investigation. In this review, we discuss the potential mechanisms by which MARA aABs interact with key neuronal and non-neuronal cells as well as their target autoantigens in the developing brain. Additionally, we highlight the potential impacts of these interactions on the developmental trajectories of targeted cells, resulting in an autism diagnosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.